Q3FY26 Operational PAT at ₹1,282m and EPS at ₹13.9, Grew ~39% YoY
Tepid Revenue Growth at 3.6%, Impacted by Low Offtake in Institutional Business and Flattish US Operations Compensated by Strong Ex-US Business, which Grew 20%YoY
Q3FY2026 Performance Highlights
§ Absolute gross margin at ₹7,317m, grew 8.6% YoY
§ Revenue at ₹11,946m, grew 3.6% YoY
§ Gross margin improved to 61.2%, up 280bps YoY
§ EBITDA grew 12.2% YoY to ₹2,359m, EBITDA margin at 19.8%, grew 160bps YoY
§ Ex-US Market Revenue at $64m, reported a strong growth of 20% YoY
§ Operational PAT at ₹1,282m, Grew 38.6% YoY
§ Operational EPS at ₹13.9
§ Reported PAT at ₹2,081m
Bangalore, India, February 2 2026 – Strides Pharma Science Ltd (BSE: 532531, NSE: STAR) announced its consolidated financial results for the quarter (Q3FY26) and nine months (9MFY26) ended December 31, 2025.
Financial Highlights (In ₹ m)
| Particulars | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ | 9MFY26 | 9MFY25 | YoY |
| Revenue | 11,946 | 11,537 | 3.6% | 12,208 | -2.1% | 35,352 | 33,749 | 4.7% |
| Gross Margin | 7,317 | 6,735 | 8.6% | 7,056 | 3.7% | 21,127 | 18,939 | 11.6% |
| Gross Margin % | 61.2% | 58.4% | 280 bps | 57.8% | 340 bps | 59.8% | 56.1% | 370 bps |
| EBITDA | 2,359 | 2,103 | 12.2% | 2,316 | 1.9% | 6,856 | 5,849 | 17.2% |
| EBITDA % | 19.8% | 18.2% | 160 bps | 19.0% | 80 bps | 19.4% | 17.3% | 210 bps |
| Operational PAT | 1,282 | 925 | 38.6% | 1,403 | -8.6% | 3,824 | 2,317 | 65.0% |
| Operational EPS (₹) | 13.9 | 10.0 | 38.4% | 15.2 | -8.6% | 41.5 | 25.2 | 64.7% |
Operational PAT = Reported PAT excluding exceptional items and one time income
FY25 Numbers presented reflect the restated financials post the demerger of Softgel business
Badree Komandur, MD & Group CEO, commented on the performance and said, “Strides continues to deliver a strong performance in Q3FY26 with growth primarily driven by the Other Regulated Markets and Growth Markets. Our strong focus on profitability resulted in gross margin expansion of 280bps YoY, and EBITDA margin increase of 160bps YoY to 19.8%. Operational PAT and Operational EPS registered a growth of ~38% YoY. This performance demonstrates our consistent execution as we continue to invest in sustainable, long-term growth. We are also delighted to welcome Peter Hardwick as the CEO of our North America business. His leadership experience, along with strategic insights of the region, will play a key role in driving our long term growth. Our ongoing commitment to ESG continues to be recognised, with an improved S&P Global Corporate Sustainability Assessment score of 80, marking a 5 point increase over the previous year.”
